ACTRN12616000204448终止未知
A pragmatic, multi-centre, parallel design (1:1:1), open, randomised controlled trial to evaluate the effectiveness of a simple short message service (sms) vs tailored sms and home visiting compared to usual parent/carer practice to improve the uptake and timeliness of the primary immunisation series in children aged less than 2 years
适应症
试验速览
- 阶段
- 未知
- 状态
- 终止
- 入组人数
- 516
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 12 Years 至 45 Years（—）
- 性别
- Female
入选标准
- •(i) Mother in the 2nd or 3rd trimester of pregnancy
- •(ii) Not planning to move from the study area until the infant turns 8 months of age
- •(iii) Access to a mobile phone
- •(iv) Provision of written informed consent from the mother
- •(v) Caboolture Community Medical l or Carbal are the family’s usual health care provider.
- •(vii) For the RCT component, a live born infant
排除标准
- •None will apply
研究者
相似试验
招募中
Unknown
A multicenter, randomized, parallel design, double-blind, superiority test, prospective clinical trial to confirm the safety and effectiveness of symptom improvement when applying low-output light irradiation device (Bye-Vi) to cold patients.KCT0008894anobioimaging58
已完成
不适用
Eficacia de TAK-559 en el tratamiento de sujetos con diabetes mellitus tipo 2.-E149 Unspecified diabetes mellitus, without complicationsUnspecified diabetes mellitus, without complicationsE149PER-087-03TAKEDA PHARMACEUTICALS,
已完成
不适用
A STUDY OF PARALLEL DESIGN, MULTICENTER, DOUBLE BLIND, RANDOMIZED, CONTROLLED ON THE SAFETY AND EFFICACY OF TAK-559 COMPARED WITH PLACEBO IN THE TREATMENT OF PATIENTS WITH DIABETES MELLITUS TYPE 2.-E149 Unspecified diabetes mellitus, without complicationsUnspecified diabetes mellitus, without complicationsE149PER-089-03TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER, INC.,
招募中
不适用
Donepezil for Visuospatial dysfunction in Mild Cognitive ImpairmentDiseases of the nervous systemKCT0006236Jeonbuk National University Hospital70
进行中（未招募）
1 期
A multi-centre, randomized, two-armed, parallel group and evaluator-blinded study of efficacy and safety of topical MOB015B in the treatment of mild to moderate distal subungual onychomycosis (DSO )Distal Subungual OnychomycosisMedDRA version: 20.0Level: PTClassification code 10030338Term: OnychomycosisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2016-001204-39-DEMoberg Pharma AB (publ)452